Recent News
​
July 20, 2021
​
Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP
​
June 30, 2021
Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase
June 15, 2021
​
June 9, 2021
May 18, 2021
May 7, 2021
​
​
April 21, 2021
​
April 14, 2021
April 7, 2021
March 31, 2021
March 16, 2021
Oncology Pharma Reveals Strategic Plans for Company Growth and Focus
March 10, 2021
March 4, 2021
Oncology Pharma Moves to Fund Lead Drug Formulation & IND-Enabling Studies
​
​
February 26, 2021
​
​
February 22, 2021
​
​
​
February 16, 2021
​
Oncology Pharma is Pleased to Welcome New Chairman to its Scientific Advisory Board
​
February 9, 2021
​
February 3, 2021
​
​
​
January 28, 2021
​
Oncology Pharma Announces the Appointment of New Chief Financial Officer
August 27, 2020
​
April 21, 2020
​
​
April 6, 2020
​
​
​
March 11, 2020
Oncology Pharma Continues Licensing Agreement with NanoSmart
January 28, 2020
​
Oncology Pharma, Inc. Narrows Focus on Funding Efforts
​
​
2019
December 26, 2019
​
Oncology Pharma Receives LOI for Financing for US$ 38.4M from SCP Investment Partners, Ltd.
December 11, 2019
Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.
November 6, 2019
October 15, 2019
October 8, 2019
Oncology Pharma Elects Dr. Stefan Gruenwald (MD, Ph.D.) to its Board of Directors
September 30, 2019
August 19, 2019
July 15, 2019
Oncology Pharma Appoints Stefan Gruenwald (MD. Ph.D) as an Advisor on its Advisory Board
June 17, 2019
SourcingLink.net Announces Corporate Name Change to Oncology Pharma, Inc.